IBO
Price:
$0.6457
Market Cap:
$5.50M
Impact BioMedical Inc. engages in the discovery and development of products and treatment options in specialty biopharmaceuticals and consumer healthcare. It provides Linebacker, a platform of small molecule electrophilically enhanced polyphenol compounds with application in oncology, inflammatory disorders, and neurology; and Laetose technology that is derived from a unique combination of sugar and inositol, which can inhibit the inflammatory and metabolic response of sugar alone. The company also develops functional fragrance formulation, a suite of functional fragrances containing specialized botanical ingredients with application as an antimicrobial, and as an additive in insect repellen...[Read more]
Industry
Biotechnology
IPO Date
Stock Exchange
AMEX
Ticker
IBO
According to Impact BioMedical Inc.’s latest financial reports and current stock price. The company's current ROE is -304.82%. This represents a change of 398.53% compared to the average of -61.14% of the last 4 quarters.
The mean historical ROE of Impact BioMedical Inc. over the last ten years is -118.39%. The current -304.82% ROE has changed 157.48% with respect to the historical average. Over the past ten years (40 quarters), IBO's ROE was at its highest in in the March 2021 quarter at 1.87%. The ROE was at its lowest in in the July 2022 quarter at -166.16%.
Average
-118.39%
Median
-128.02%
Minimum
-266.20%
Maximum
0%
Discovering the peaks and valleys of Impact BioMedical Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 150.50%
Maximum Annual ROE = 0%
Minimum Annual Increase = -Infinity%
Minimum Annual ROE = -266.20%
Year | ROE | Change |
---|---|---|
2022 | -266.20% | 102.65% |
2021 | -131.36% | 5.36% |
2020 | -124.68% | 150.50% |
2019 | -49.77% | -64.01% |
2018 | -138.30% | -Infinity% |
The current ROE of Impact BioMedical Inc. (IBO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-174.08%
5-year avg
-142.06%
10-year avg
-118.39%
Impact BioMedical Inc.’s ROE is less than Ellomay Capital Ltd. (4.30%), less than Eagle Capital Growth Fund, Inc. (12.16%), less than Merrill Lynch Depositor Inc. 6.0518% Index Plus Trust Series 2003-1 (0%),
Company | ROE | Market cap |
---|---|---|
4.30% | $218.49M | |
12.16% | $39.32M | |
0% | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Impact BioMedical Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Impact BioMedical Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Impact BioMedical Inc.'s ROE?
How is the ROE calculated for Impact BioMedical Inc. (IBO)?
What is the highest ROE for Impact BioMedical Inc. (IBO)?
What is the 3-year average ROE for Impact BioMedical Inc. (IBO)?
What is the 5-year average ROE for Impact BioMedical Inc. (IBO)?
How does the current ROE for Impact BioMedical Inc. (IBO) compare to its historical average?